The remaining 34 patients received a combination of different PD drugs such as levodopa, dopamine agonists, Catechol‐O‐methyltransferase (COMT) inhibitors, MAO‐B inhibitors, or amantadine (Table S1). This evidence concerns the gene MAOB and Parkinson disease.